What is NDC 64764-800?

64764-800 is the product NDC for Livtencity (maribavir), Maribavir 200 mg/1 tablet, coated, listed with the FDA by Takeda Pharmaceuticals America, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Takeda Pharmaceuticals America, Inc., NDC labeler code 64764. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Livtencity?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Livtencity NDC 64764-800 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)64764-800Labeler and product segments. Claims need a package NDC.

Product NDC at billing width64764-0800Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
64764-800-28	64764080028	1 BOTTLE in 1 CARTON (64764-800-28) / 28 TABLET, COATED in 1 BOTTLEMarketed from Nov 23, 2021
64764-800-56	64764080056	1 BOTTLE in 1 CARTON (64764-800-56) / 56 TABLET, COATED in 1 BOTTLEMarketed from Nov 23, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Livtencity
Generic name (nonproprietary): maribavir
Active ingredients: Maribavir — 200 mg/1
Dosage form: Tablet, Coated
Route: Oral
Labeler: Takeda Pharmaceuticals America, Inc.NDC labeler code 64764
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 215596
Marketing start: Nov 23, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Breast Cancer Resistance Protein Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)Cytomegalovirus pUL97 Kinase Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
Identifiers: Product ID 64764-800_14acb19d-0258-47df-a01a-bdca1ea05e54SPL ID 14acb19d-0258-47df-a01a-bdca1ea05e54SPL set ID c94fc2c5-e840-4f18-b7d8-d5eacb26d3a0RxCUI 2586073, 2586079UNII PTB4X93HE1
Pharmacologic class: Cytomegalovirus pUL97 Kinase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N464764080028 followed by a unit qualifier and the quantity

Package 64764-0800-28. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 27, 2026.

Indications (excerpt from the label)

LIVTENCITY ® is indicated for the treatment of adults and pediatric patients (12 years of age and older and weighing at least 35 kg) with post-transplant cytomegalovirus (CMV) infection/disease that is refractory to treatment (with or without genotypic resistance) with ganciclovir, valganciclovir, cidofovir or foscarnet [see Use in Specific Populations (8.4) and Clinical Studies (14) ] . LIVTENCITY is a cytomegalovirus (CMV) pUL97 kinase inhibitor indicated for the treatment of adults and pediatric patients (12 years of age and older and weighing at least 35 kg) with post-transplant CMV infection/disease that is refractory to treatment (with or without genotypic resistance) with ganciclovir,…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 64764-800

What is NDC 64764-800?: 64764-800 is the product NDC for Livtencity (maribavir), Maribavir 200 mg/1 tablet, coated, listed with the FDA by Takeda Pharmaceuticals America, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Livtencity (Maribavir).
What is the active ingredient?: Maribavir.
Who is the labeler?: Takeda Pharmaceuticals America, Inc., NDC labeler code 64764. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Livtencity?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Livtencity (Maribavir) NDC 64764-800